Here, we show that EGFR activation leads to the phosphorylation of one of the core Hippo pathway components, MOB1 to inhibit LATS1/2 function thus resulting in YAP/TAZ activation in HNSCC cells independent of FAT1 alterations. This evidence concerns the gene FAT1 and head and neck squamous cell carcinoma.